Liminatus Pharma is a preclinical oncology company focused on a CD47 antibody. Check out why I see little reason for ...

The startup is one of several that have recently raised mega rounds of financing to support programs in the clinic or ...

Myelodysplastic syndromes are haematopoietic stem cell neoplasms with characteristic dysplasia in the blood and bone marrow cells resulting in ineffective haematopoiesis, cytopenias, and increased ...